295 related articles for article (PubMed ID: 32037528)
1. Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
Kotsopoulos J; Narod SA
Int J Cancer; 2020 Sep; 147(5):1245-1251. PubMed ID: 32037528
[TBL] [Abstract][Full Text] [Related]
2. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador S; Scott S; Francis JA; Agrawal A; Giede C
J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: A reappraisal.
Oliver Perez MR; Magriñá J; García AT; Jiménez Lopez JS
Surg Oncol; 2015 Dec; 24(4):335-44. PubMed ID: 26690823
[TBL] [Abstract][Full Text] [Related]
4. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
[TBL] [Abstract][Full Text] [Related]
5. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
[TBL] [Abstract][Full Text] [Related]
6. Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomy.
Ayres C; Ratnayake G; McNally O; Quinn M
Int J Gynecol Cancer; 2017 May; 27(4):703-707. PubMed ID: 28399030
[TBL] [Abstract][Full Text] [Related]
7. Salpingectomy for the Risk Reduction of Ovarian Cancer: Is It Time for a Salpingectomy-alone Approach?
Boerner T; Long Roche K
J Minim Invasive Gynecol; 2021 Mar; 28(3):403-408. PubMed ID: 33038519
[TBL] [Abstract][Full Text] [Related]
8. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
[TBL] [Abstract][Full Text] [Related]
9. Current Updates on Salpingectomy for the Prevention of Ovarian Cancer and Its Practice Patterns Worldwide.
Dhakal S; Zheng YX; Yi XF
Chin Med Sci J; 2017 Sep; 32(3):185-192. PubMed ID: 28956746
[TBL] [Abstract][Full Text] [Related]
10. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
[TBL] [Abstract][Full Text] [Related]
11. Fallopian tube tumorigenesis and clinical implications for ovarian cancer risk-reduction.
Gockley AA; Elias KM
Cancer Treat Rev; 2018 Sep; 69():66-71. PubMed ID: 29909222
[TBL] [Abstract][Full Text] [Related]
12. Role of Fallopian Tubes in the Development of Ovarian Cancer.
Corzo C; Iniesta MD; Patrono MG; Lu KH; Ramirez PT
J Minim Invasive Gynecol; 2017 Feb; 24(2):230-234. PubMed ID: 28007588
[TBL] [Abstract][Full Text] [Related]
13. Salpingectomy as a means to reduce ovarian cancer risk.
Daly MB; Dresher CW; Yates MS; Jeter JM; Karlan BY; Alberts DS; Lu KH
Cancer Prev Res (Phila); 2015 May; 8(5):342-8. PubMed ID: 25586903
[TBL] [Abstract][Full Text] [Related]
14. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.
Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE
J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912
[TBL] [Abstract][Full Text] [Related]
15. Surgical implications of the potential new tubal pathway for ovarian carcinogenesis.
Chene G; Rahimi K; Mes-Masson AM; Provencher D
J Minim Invasive Gynecol; 2013; 20(2):153-9. PubMed ID: 23332575
[TBL] [Abstract][Full Text] [Related]
16. Can we prevent ovarian cancer?
Aus AT
Ceska Gynekol; 2020; 85(1):49-58. PubMed ID: 32414285
[TBL] [Abstract][Full Text] [Related]
17. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
[TBL] [Abstract][Full Text] [Related]
18. Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO.
Pölcher M; Hauptmann S; Fotopoulou C; Schmalfeldt B; Meinhold-Heerlein I; Mustea A; Runnebaum I; Sehouli J
Arch Gynecol Obstet; 2015 Jul; 292(1):231-4. PubMed ID: 25914073
[TBL] [Abstract][Full Text] [Related]
19. Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.
Pérez-López FR; Ceausu I; Depypere H; Kehoe S; Lambrinoudaki I; Mueck A; Senturk LM; Simoncini T; Stevenson JC; Stute P; Rees M
Maturitas; 2017 Jun; 100():86-91. PubMed ID: 28389043
[TBL] [Abstract][Full Text] [Related]
20. Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial.
Gaba F; Robbani S; Singh N; McCluggage WG; Wilkinson N; Ganesan R; Bryson G; Rowlands G; Tyson C; Arora R; Saridogan E; Hanson H; Burnell M; Legood R; Evans DG; Menon U; Manchanda R;
Int J Gynecol Cancer; 2021 Feb; 31(2):286-291. PubMed ID: 32907814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]